Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-16

Clinical Trial Update: Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception [Phase 3]

View source ↗

Summary

Phase 3 trial comparing CDB-2914 to levonorgestrel for emergency contraception completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CDB-2914 (Ulipristal acetate)
  • Levonorgestrel (Levonorgestrel)

Snippet

Sponsor: HRA Pharma | Conditions: Contraception | Phase 3 | Status: COMPLETED | Results posted: 2022-03-16